Proposed Enhancing CLIA Act Seeks to Reshape Lab Test Oversight
Representative Neal Dunn has introduced the Enhancing Clinical Laboratory Innovation and Access Act of 2026, marking the first congressional attempt to define the oversight of laboratory-developed tests since a 2025 court ruling effectively blocked the FDA from regulating these diagnostic tools as medical devices.
























